RecruitingNCT04853251
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
PHASE4 · 188 planned enrolment
- Countries listed
- 1
- Registry update
- October 2, 2026
